156 related articles for article (PubMed ID: 10428944)
1. Role of permeability in the activities of beta-lactams against gram-negative bacteria which produce a group 3 beta-lactamase.
Matsumura N; Minami S; Watanabe Y; Iyobe S; Mitsuhashi S
Antimicrob Agents Chemother; 1999 Aug; 43(8):2084-6. PubMed ID: 10428944
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
Aktaş Z; Kayacan C; Oncul O
Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
[TBL] [Abstract][Full Text] [Related]
3. Effect of interaction between outer membrane permeability and beta-lactamase production on resistance to beta-lactam agents in gram-negative bacteria.
Sawai T; Yamaguchi A; Hiruma R
Rev Infect Dis; 1988; 10(4):761-4. PubMed ID: 3055174
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Park YJ; Yu JK; Park KG; Park YG; Lee S; Kim SY; Jeong SH
Diagn Microbiol Infect Dis; 2011 Sep; 71(1):87-9. PubMed ID: 21397426
[TBL] [Abstract][Full Text] [Related]
5. NDM-1 (New Delhi metallo beta lactamase-1) producing Gram-negative bacilli: emergence & clinical implications.
Fomda BA; Khan A; Zahoor D
Indian J Med Res; 2014 Nov; 140(5):672-8. PubMed ID: 25579151
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity of T-5575, a novel 2-carboxypenam, and its stability to beta-lactamase.
Matsumura N; Minami S; Mitsuhashi S
J Antimicrob Chemother; 1997 Jan; 39(1):31-4. PubMed ID: 9044025
[TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
Zarakolu P; Hasçelik G; Unal S
Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
[TBL] [Abstract][Full Text] [Related]
8. Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes.
Siu LK; Lu PL; Hsueh PR; Lin FM; Chang SC; Luh KT; Ho M; Lee CY
J Clin Microbiol; 1999 Dec; 37(12):4020-7. PubMed ID: 10565924
[TBL] [Abstract][Full Text] [Related]
9. Mutant prevention concentrations of four carbapenems against gram-negative rods.
Credito K; Kosowska-Shick K; Appelbaum PC
Antimicrob Agents Chemother; 2010 Jun; 54(6):2692-5. PubMed ID: 20308376
[TBL] [Abstract][Full Text] [Related]
10. Genetic features of blaNDM-1-positive Enterobacteriaceae.
Poirel L; Dortet L; Bernabeu S; Nordmann P
Antimicrob Agents Chemother; 2011 Nov; 55(11):5403-7. PubMed ID: 21859933
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
[TBL] [Abstract][Full Text] [Related]
12. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
Spencer RC
Scand J Infect Dis Suppl; 1993; 91():25-32. PubMed ID: 8290900
[TBL] [Abstract][Full Text] [Related]
13. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
Medeiros AA; Hare R; Papa E; Adam C; Miller GH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
[TBL] [Abstract][Full Text] [Related]
14. Aztreonam-Avibactam Combination Restores Susceptibility of Aztreonam in Dual-Carbapenemase-Producing Enterobacteriaceae.
Chew KL; Tay MKL; Cheng B; Lin RTP; Octavia S; Teo JWP
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760136
[No Abstract] [Full Text] [Related]
15. Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).
Pfaller MA; Jones RN; Marshall SA; Coffman SL; Hollis RJ; Edmond MB; Wenzel RP
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):211-9. PubMed ID: 9327251
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of Sch 34343 against Gram-negative bacteria producing characterized beta-lactamases.
Dornbusch K; Frolander F; Cacciapuoti AF; Naples L; Hare RS; Miller GH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():85-97. PubMed ID: 3897175
[TBL] [Abstract][Full Text] [Related]
17. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
18. Induction of plasmid-mediated AmpC β-lactamase DHA-1 by piperacillin/tazobactam and other β-lactams in Enterobacteriaceae.
Akata K; Muratani T; Yatera K; Naito K; Noguchi S; Yamasaki K; Kawanami T; Kido T; Mukae H
PLoS One; 2019; 14(7):e0218589. PubMed ID: 31283769
[TBL] [Abstract][Full Text] [Related]
19. Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
Padilla E; Alonso D; Doménech-Sánchez A; Gomez C; Pérez JL; Albertí S; Borrell N
Antimicrob Agents Chemother; 2006 Jun; 50(6):2258-60. PubMed ID: 16723600
[TBL] [Abstract][Full Text] [Related]
20. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.
Shannon K; Phillips I
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
